Ibrutinib use, treatment duration, and concomitant medications in Australian patients with relapsed or refractory chronic lymphocytic leukaemia

Stephen P. Mulligan, Stephen Opat, Paula Marlton, Bryone Kuss, Poppy Gerungan, Andrea Puig, Marija McGeachie, Constantine S. Tam

Research output: Contribution to journal › Letter › peer-review

6 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Ibrutinib use, treatment duration, and concomitant medications in Australian patients with relapsed or refractory chronic lymphocytic leukaemia'. Together they form a unique fingerprint.

Medicine and Dentistry